BlackRock Investment Management’s Eledon Pharmaceuticals ELDN Stock Holding History

BlackRock Investment Management’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$34K	Buy	217 +10	+5%	+$1.92K	﹤0.01%	3327
2016 Q3	$51K	Sell	207 -1	-0.5%	-$366	﹤0.01%	3294
2016 Q2	$186K	Sell	208 -8	-4%	-$8.83K	﹤0.01%	3277
2016 Q1	$197K	Buy	216 +1	+0.5%	+$982	﹤0.01%	3162
2015 Q4	$303K	Buy	215 +1	+0.5%	+$1.74K	﹤0.01%	3161
2015 Q3	$359K	Sell	214 -2	-0.9%	-$4.12K	﹤0.01%	3129
2015 Q2	$465K	Buy	216 +106	+96%	+$205K	﹤0.01%	3146
2015 Q1	$201K	Buy	110 +12	+12%	+$26.5K	﹤0.01%	3217
2014 Q4	$233K	Buy	+98	New	+$233K	﹤0.01%	3234

Other funds holding ELDN

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Investment Management's ELDN Position: Q4 2016 in Review

BlackRock Investment Management increased its Eledon Pharmaceuticals (ELDN) stake by 4.8% in Q4 2016, buying an estimated $1.92K and bringing the position to 217 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #3327.

BlackRock Investment Management first reported a position in ELDN in Q4 2014 and has held it in 9 quarters since. The position peaked at $465K in Q2 2015. 42 funds tracked by Wall St. Rank hold ELDN as of Q4 2016.

BlackRock Investment Management held 217 shares of Eledon Pharmaceuticals worth $34K as of Q4 2016.
BlackRock Investment Management bought 10 Eledon Pharmaceuticals shares in Q4 2016, an estimated $1.92K.
Eledon Pharmaceuticals made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3327 holding.
BlackRock Investment Management first reported a position in Eledon Pharmaceuticals in Q4 2014 and has held it in 9 quarters since.
BlackRock Investment Management's Eledon Pharmaceuticals position peaked at $465K in Q2 2015.
42 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.